VA HB1214

Reduces the maximum cost-sharing payment for prescription insulin from $50 to $35 per 30-day supply, with the cap applying in aggregate when a patient is prescribed multiple insulin drugs

Establishes a new $35 per 30-day supply cap on cost-sharing for diabetes equipment and supplies, including blood glucose meters and strips, urine-testing strips, syringes, continuous glucose monitors, and insulin pump supplies

Specifies that diabetes equipment and supplies are not classified as durable medical equipment, which affects how insurers must cover these items

Applies to individual and group hospital policies, major medical policies, subscription contracts, and health maintenance organization plans in Virginia

Takes effect for insurance policies delivered, issued, reissued, amended, or extended on or after January 1, 2027